GOLDMAN

Singular Genomics to Present at the Goldman Sachs Global Healthcare Conference

Retrieved on: 
Wednesday, May 29, 2024
Singular, NGS, OMIC, SAN, Conference

SAN DIEGO, May 29, 2024 (GLOBE NEWSWIRE) -- Singular Genomics Systems, Inc. (Nasdaq: OMIC), a company leveraging novel next-generation sequencing (NGS) and spatial multiomics technologies to empower researchers and clinicians, today announced plans to present at the Goldman Sachs 45th Annual Global Healthcare Conference in Miami, Florida.

Key Points: 
  • SAN DIEGO, May 29, 2024 (GLOBE NEWSWIRE) -- Singular Genomics Systems, Inc. (Nasdaq: OMIC), a company leveraging novel next-generation sequencing (NGS) and spatial multiomics technologies to empower researchers and clinicians, today announced plans to present at the Goldman Sachs 45th Annual Global Healthcare Conference in Miami, Florida.
  • Singular Genomics’ management is scheduled to participate in a fireside chat Wednesday, June 12, 2024, at 7:40 a.m. Pacific Time / 10:40 a.m. Eastern Time.
  • Investors and other interested parties are invited to listen to a live and recorded webcast of the presentation at investor.singulargenomics.com in the Presentations & Events section.

Adaptive Biotechnologies to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference

Retrieved on: 
Wednesday, May 29, 2024
ADPT, Interest, Conference, Genetics

SEATTLE, May 29, 2024 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune system into clinical products to diagnose and treat disease, today announced it will be participating in the upcoming Goldman Sachs 45th Annual Global Healthcare Conference in Miami, FL.

Key Points: 
  • SEATTLE, May 29, 2024 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune system into clinical products to diagnose and treat disease, today announced it will be participating in the upcoming Goldman Sachs 45th Annual Global Healthcare Conference in Miami, FL.
  • Adaptive Biotechnologies’ management is scheduled to participate in a fireside chat on Tuesday, June 11th at 10:20 a.m. Pacific Time / 1:20 p.m. Eastern Time.
  • Interested parties may access a live and archived webcast of the presentation on the “Investors” section of the company website at: www.adaptivebiotech.com .

Erasca to Present at Upcoming Investor Conferences in June

Retrieved on: 
Wednesday, May 29, 2024
Conference, Patient, SAN

SAN DIEGO, May 29, 2024 (GLOBE NEWSWIRE) -- Erasca, Inc. (Nasdaq: ERAS), a clinical-stage precision oncology company singularly focused on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers, today announced that Jonathan E. Lim, M.D., chairman, CEO, and co-founder, and David M. Chacko, M.D., chief financial officer and chief business officer, will participate in the following investor conferences in June 2024, and will also participate in one-on-one investor meetings.

Key Points: 
  • SAN DIEGO, May 29, 2024 (GLOBE NEWSWIRE) -- Erasca, Inc. (Nasdaq: ERAS), a clinical-stage precision oncology company singularly focused on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers, today announced that Jonathan E. Lim, M.D., chairman, CEO, and co-founder, and David M. Chacko, M.D., chief financial officer and chief business officer, will participate in the following investor conferences in June 2024, and will also participate in one-on-one investor meetings.
  • Jefferies Global Healthcare Conference (June 5 – 6, 2024)
    Goldman Sachs 45th Annual Global Healthcare Conference (June 10 – 13, 2024)

NewAmsterdam Pharma to Participate in Upcoming Investor Conferences in June

Retrieved on: 
Wednesday, May 29, 2024
Patient, Cardiovascular disease, Risk, Conference, NAMS

Michael Davidson, M.D., Chief Executive Officer, and Ian Somaiya, Chief Financial Officer, will participate in a fireside chat at 3:00 p.m.

Key Points: 
  • Michael Davidson, M.D., Chief Executive Officer, and Ian Somaiya, Chief Financial Officer, will participate in a fireside chat at 3:00 p.m.
  • ET; and
    Goldman Sachs 45th Annual Global Healthcare Conference in Miami Beach, FL on Monday, June 10, 2024.
  • Michael Davidson, M.D., Chief Executive Officer, will present a corporate overview at 10:40 a.m.
  • Live webcasts of both presentations will be available through the investor relations section of the NewAmsterdam Pharma website at ir.newamsterdampharma.com .

Kymera Therapeutics to Participate in Upcoming June Investor Conferences

Retrieved on: 
Wednesday, May 29, 2024
News, Therapy, Conference, TPD

WATERTOWN, Mass., May 29, 2024 (GLOBE NEWSWIRE) -- Kymera Therapeutics, Inc. (NASDAQ: KYMR), a clinical-stage biopharmaceutical company advancing a new class of small molecule medicines using targeted protein degradation (TPD), today announced that the Company will participate in fireside chats at the following upcoming investor events:

Key Points: 
  • WATERTOWN, Mass., May 29, 2024 (GLOBE NEWSWIRE) -- Kymera Therapeutics, Inc. (NASDAQ: KYMR), a clinical-stage biopharmaceutical company advancing a new class of small molecule medicines using targeted protein degradation (TPD), today announced that the Company will participate in fireside chats at the following upcoming investor events:
    Jefferies 2024 Global Healthcare Conference in New York, NY on June 5 at 11:30 a.m.
  • ET; and
    Goldman Sachs 45th Annual Global Healthcare Conference in Miami, FL on June 11 at 2:40 p.m.
  • Live webcasts of the presentations will be available under “ News and Events ” in the Investors section of the Company’s website at www.kymeratx.com.
  • Replays of the webcasts will be archived and available following the events.

Vir Biotechnology to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference

Retrieved on: 
Wednesday, May 29, 2024
AIDS, Health, Infectious Diseases, Clinical Trials, Pharmaceutical, Biotechnology, MBA, Vir, Conference

Vir Biotechnology, Inc. (Nasdaq: VIR) today announced that Marianne De Backer, M.Sc., Ph.D., MBA, Chief Executive Officer is scheduled to participate in a fireside chat at the Goldman Sachs 45th Annual Global Healthcare Conference on Wednesday, June 12, at 11:00 a.m. PT / 2:00 p.m.

Key Points: 
  • Vir Biotechnology, Inc. (Nasdaq: VIR) today announced that Marianne De Backer, M.Sc., Ph.D., MBA, Chief Executive Officer is scheduled to participate in a fireside chat at the Goldman Sachs 45th Annual Global Healthcare Conference on Wednesday, June 12, at 11:00 a.m. PT / 2:00 p.m.
  • ET at the Loews Miami Beach Hotel, Miami Beach, Florida.
  • A live webcast of the fireside chat will be made available under Events & Presentations in the Investors section of the Vir website at www.vir.bio and will be archived there for 30 days.

Saghmos Therapeutics Announces Presentation at the Goldman Sachs 45th Annual Global Healthcare Conference

Retrieved on: 
Wednesday, May 29, 2024
Biotechnology, General Health, Health, Pharmaceutical, Cardiology, Therapy, Webcast, Risk, Conference, Trimetazidine, PCI

Saghmos Therapeutics, Inc. (Saghmos), a privately held biopharmaceutical company poised to enter a Phase 3 study of ST-62516 (trimetazidine) to reduce the risk of cardiorenal complications after PCI, announced its participation at the Goldman Sachs 45th Annual Global Healthcare Conference.

Key Points: 
  • Saghmos Therapeutics, Inc. (Saghmos), a privately held biopharmaceutical company poised to enter a Phase 3 study of ST-62516 (trimetazidine) to reduce the risk of cardiorenal complications after PCI, announced its participation at the Goldman Sachs 45th Annual Global Healthcare Conference.
  • Anna Kazanchyan, MD, Saghmos’ Founder and Chief Executive Officer, is scheduled to present on Wednesday, June 12th at 3:20pm Eastern Time.
  • A live webcast of the session will be accessible at https://cc.webcasts.com/gold006/061024a_js/?entity=49_TLJGW65 .
  • A replay of the webcast will be available shortly after the presentation.

Foghorn Therapeutics to Participate in Upcoming Investor Conferences in June

Retrieved on: 
Tuesday, May 28, 2024
Conference, Gene expression, New York Marriott Marquis

With an initial focus in oncology, Foghorn’s Gene Traffic Control® platform and resulting broad pipeline have the potential to transform the lives of people suffering from a wide spectrum of diseases.

Key Points: 
  • With an initial focus in oncology, Foghorn’s Gene Traffic Control® platform and resulting broad pipeline have the potential to transform the lives of people suffering from a wide spectrum of diseases.
  • Presentation: Wednesday, June 5, 2024, at 3:30 p.m.
  • ET at the Marriott Marquis New York, New York
    Management will also participate in one-on-one meetings on Wednesday, June 5
    Presentation: Monday, June 10, 2024, at 3:20 p.m.
  • ET at the Loews Miami Beach Hotel, Miami Beach, Florida
    A webcast of both presentations can be accessed under “ Events & Presentations ” in the Investors section of the Company’s website, www.foghorntx.com , and will be available for 30 days.

Phathom Pharmaceuticals to Participate in Upcoming Investor Conferences

Retrieved on: 
Tuesday, May 28, 2024
Conference, News

FLORHAM PARK, N.J., May 28, 2024 (GLOBE NEWSWIRE) --  Phathom Pharmaceuticals, Inc. (Nasdaq: PHAT), a biopharmaceutical company focused on developing and commercializing novel treatments for gastrointestinal (GI) diseases, announced today that members of its management team are scheduled to participate in the following investor conferences in June:

Key Points: 
  • FLORHAM PARK, N.J., May 28, 2024 (GLOBE NEWSWIRE) --  Phathom Pharmaceuticals, Inc. (Nasdaq: PHAT), a biopharmaceutical company focused on developing and commercializing novel treatments for gastrointestinal (GI) diseases, announced today that members of its management team are scheduled to participate in the following investor conferences in June:
    Jefferies Global Healthcare Conference in New York, NY
    Goldman Sachs 45th Annual Global Healthcare Conference in Miami Beach, FL
    To access the live webcast and archived recordings of each event, visit the News & Events section of the Phathom website at https://investors.phathompharma.com/news-events/events-and-presentations .
  • Recordings will be available for 90 days following the conclusion of each meeting.

Absci to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference

Retrieved on: 
Tuesday, May 28, 2024
Interest, Conference

VANCOUVER, Wash. and NEW YORK, May 28, 2024 (GLOBE NEWSWIRE) -- Absci Corporation (Nasdaq: ABSI), a data-first generative AI drug creation company, today announced the company will be participating in the upcoming Goldman Sachs 45th Annual Global Healthcare Conference in Miami, FL.

Key Points: 
  • VANCOUVER, Wash. and NEW YORK, May 28, 2024 (GLOBE NEWSWIRE) -- Absci Corporation (Nasdaq: ABSI), a data-first generative AI drug creation company, today announced the company will be participating in the upcoming Goldman Sachs 45th Annual Global Healthcare Conference in Miami, FL.
  • Absci management is scheduled to present on Monday, June 10th at 2:00 p.m. Eastern Time (11:00 a.m. Pacific Time).
  • Interested parties may access a live and archived webcast on the company’s investor relations website at: investors.absci.com .